



Researchers at the University ofWisconsin
at Madison have completed the first in situ
molecular-level study of microbes that
mediate toxic pollutants associated with
sulfide mining. Tracking the volume and
distribution of bacteria in an abandoned
California mine, they may have found a
better way to predict the potential environ-
mental consequences of mining metallic
sulfide ores.
One of the harshest environmental
effects of sulfide mining is acid mine
drainage (AMD), in which sulfuric acid
flows into groundwater and surface water
from metallic ore mines, releasing and sus-
pending potentially toxic heavy metals in
the water. In nature, sulfuric acid forms
when minerals are exposed to oxygen and
water; in mines, when pyrite and other sul-
fide minerals are exposed to oxygen and
water in the surfaces of tailings and ore
bodies, they oxidize to create ferrous and
sulfuric acid. Catalyzed by naturally occur-
ring bacteria, the ferrous ions react further
with oxygen, producing a hydrated iron
oxide called "yellowboy." Yellowboy and
sulfuric acid may lower the pH of local
soil, groundwater, and surface water, creat-
ing an unpredictable and potentially severe
reaction. Two species of bacteria-
Thiobacillusferrooxidans and Leptospirillum
ferrooxidans-have traditionally been
thought to be the main microbes involved
in acceleratingAMD.
AMD can be a big problem at aban-
doned mine sites. A 1993 U.S. Forest
Service survey, Acid Mine Drainagefrom
Mines on National Forests: A Management
Challenge, estimated that up to 10,000
miles of domestic streams and rivers are
affected by AMD, which makes the
waters corrosive and harmful to some ani-
mal and plant life. Drainage water can
also carry toxic metal-bearing sediment
into streams. According to the 1994
Technical Document/Backgroundfor EPA
Reviews: Non-Coal Mining Operations,
prepared by the EPA's Office of Solid
Waste, AMD can jeopardize surface water
and groundwater quality and other
resources during active mining and for
decades after operations cease.
The UW-Madison study was conduct-
ed at an abandoned iron mine in Iron
Mountain, California. The results, pro-
duced using molecular biology techniques
to assess population dynamics of the
microbes in the wild, suggest that contrary
to earlier beliefs, L. ferrooxidans is a bigger
contributor than T. ferrooxidans to mine
pollution. The findings could give the min-
ing industry and others a new predictive
Bathing the earth in acid. New research on the role of bacteria in accelerating acid mine drainage may
help researchers predictthe release ofsulfuric acid and hydrated iron oxide from industrial mining sites,
thus allowing themtotake preventive actionsto protectthe environment.
tool for estimating AMD from a given
industrial site.
Mining at Iron Mountain was done in
above-ground pits and in the tunnels. The
Wisconsin team explored AMD under geo-
chemical conditions in both environments.
Results showed that T. ferrooxidans prefers
moderate temperatures and lower acidity
levels, whereas L. ferrooxidans survives at
much higher temperatures and acid con-
centrations. This suggests L. ferrooxidans
has a bigger role in accelerating AMD
because its chances of coming in contact
with theorebodyare greater.
Researchers were surprised to find that
T. ferrooxidans isn't the predominant
player it was presumed to be; in fact,
inside the mine, where mostAMD occurs,
it's essentially undetectable. L. ferrooxi-
dans is far more present in the mine,
where it makes up as much as 50% ofthe
microbe species found in the mine's miles
ofunderground tunnels.
"One interesting aspect of the work,"
says study coauthor and UW-Madison
chemistry professor Robert Hamers, "is
that the bacteria are finely tuned to their
specific environments. I suspect similar bac-
teria are present in other mines as well, but
I can't make a global statement to that
effect. Temperature, pH, and metal con-
centrations all could affect the bacteria. In
fact, we knowthere are seasonal variations."
Hamers continues, "It is believed that most
bacteria found in these extreme environ-
ments derive at least part oftheir metabolic
energy by oxidizing iron from a 2+ oxida-
tion state [ferrous ion] to a 3+ oxidation
state [ferric ion]. The bacteria produces
iron 3+, a strong oxidizing agent that can
dissolve the mineral and liberate even
more iron 2+. So bacteria and minerals are
part ofa cycle-the bacteria derive energy
from oxidizing iron, and iron dissolves the
minerals and becomes reduced in the
process. This acts as more food for the
[bacteria], and the process continues.
Some bacteria may also be able to derive
energy byoxidizing sulfur."
Finally, says Hamers, "Oneaspectthat's
still controversial is whether the bacteria
actually attach themselves to the mineral
surface, or whether the interaction occurs
remotely through the ferric and ferrous
ions." The researchers still have many ques-
tions about these other mine-dwelling bac-
teria, such as what they are, whether they
are related to previously known bacteria or
whether they represent a new genus or
species, and howthey tolerate such extreme
metal concentrations and pH levels.
As for the UW-Madison study results,
Hamers says the question now is whether
the microbes offerany real predictive ability
at the present time. "People are not able to
accurately predict in a quantitative way the
rates at which acid mine drainage is
formed," he says. "Part of the problem is
that the importance of bacteria in creating
the acidic drainage has only been recog-
nized fairlyrecently, and the types ofbacte-
ria present depend on several local factors.
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However, ifall ofthese [factors] are known,
then perhaps it will be possible to better
predict-scientifically-the effects."
Hamers says such metal-tolerant bacte-
ria have potential use as removers or oxidiz-
ers of certain types of hazardous metals
from the environment. It might even be
possible, he adds, to genetically engineer
bacteria to selectively oxidize particular
metals or to work their chemistry under
beneficial circumstances. This is good news;
because the process ofremediating AMD is
so damaging and expensive, predictive
tools, design performance, financial assur-
ance, and monitoring are increasingly
important in the mining industry.
TB: New Research on An Old
Disease
Tuberculosis, which currently infects one-
third of the world's population, claims
more lives annually than any other infec-
tious disease. The World Health
Organization estimates that 8 million peo-
ple become infected and 3 million die
from tuberculosis each year.
Tuberculosis spreads when infected
people cough and sneeze, and others inhale
infectious droplets circulating in the air.
The Mycobacterium tuberculosis microbe
lodges in the lung, producing symptoms
including coughing (sometimes bloody),
chest pain, fever, and weight loss. In the
past few decades, outbreaks of tuberculosis
have been reported in hospitals, prisons,
schools, homeless shelters, bars, and facto-
ries, and passengers on commercial airlines
have been infected by neighboring travelers
and recirculating air.
As the number of new cases rises, so
does M. tuberculosis's resistance to antibi-
otics. A four-year study involving 35 coun-
tries, reported in the 4 June 1998 issue of
the New EnglandJournal ofMedicine, finds
that 36% of tuberculosis patients treated
for less than a month harbor microbes resis-
tant to at least one ofthe four main antibi-
otics used to fight the disease. According to
the report, patients need to take all four
antibiotics (isoniazid, streptomycin,
rifampin, and ethambutol) for two months,
then continue two drugs for another four
months for the therapy to be successful.
However, many patients fail to comply
with the lengthy treatment and help to
spawn drug-resistant microbes that are
immune to treatment.
Several recent scientific breakthroughs
may, however, turn the tide in the battle
against tuberculosis. An international team
led by Stewart Cole ofthe Pasteur Institute
in Paris, France, and Best Barrell of the
Wellcome Trust Genome Campus in
Cambridge, United Kingdom, sequenced
the bacterium's 4,000 genes, and published
the results in the 11 June 1998 issue of
Nature. The findings provide clues to the
bacterium's defense mechanisms. For
example, at least 250 diverse genes of the
bacterium are devoted to lipid metabolism,
more than any other bacterium sequenced.
This suggests that M. tuberculosis digests
lipids from host cells, then uses these lipids
in its own cell wall, which is notoriously
impermeable to many antibiotics. "All
those enzymes, and particularly those that
let [the microbe] use host membrane lipids
as starting materials, are important drug
targets," says Clifton Barry, head of the
A chronic culprit. Despite advances in science, tuberculosis continues to plague the modern world. New
understanding may help researchers apprehend this infectious disease.
tuberculosis section at the NIH's Rocky
Mountain Laboratory in Hamilton,
Montana, and a coauthor ofthe report.
In a separate project, Barry identified a
molecular target of isoniazid, the most
widely used antibiotic for tuberculosis.
Although isoniazid treatment dates back to
the 1950s, no one knows exactly how it
works or why some tuberculosis strains
grow resistant to it. But Barry and his col-
leagues reported in the 5 June 1998 issue of
Science that isoniazid attacks the enzyme
KasA (beta-ketoacyl-acyl carrier protein
synthase) needed to synthesize mycolic acid
for the bacterium's cell wall.
The KasA findings form the basis of a
new assay for screening tuberculosis drug
candidates. A reporter luciferase gene that
glows when a drug effectively attacks KasA
was added to an enzyme that increases
when treated with isoniazid; the light pro-
duction is easier to measure than the
enzyme activity. Barry, now an investigator
at the NIH's Laboratory of Host Defenses
in Bethesda, Maryland, and researchers at
Pharmacopeia in Princeton, New Jersey,
are screening millions of potential antitu-
berculosis compounds.
A new tool that produces large num-
bers ofmutants of M tuberculosis provides
another method for advancing new drugs
and vaccines. Generally, mutants provide
insights into a microbe's survival, route of
infection, and drug targets. However, the
lack of tools for manipulating the M.
tuberculosis genome, such as an efficient
delivery system, has hindered progress with
standard gene-modifying agents such as
transposons.
Scientists William R. Jacobs and Barry
R. Bloom of the Howard Hughes Medical
Institute at the Albert Einstein College of
Medicine in the Bronx, New York, have
developed a new vector, called a "shuttle
phasmid," to make mutants ofM tubercu-
losis. The shuttle phasmid combines a
mycobacteriophage (a virus that infects
mycobacteria) with an Escherichia coli plas-
mid. The shuttle phasmid efficiently carries
transposons inside M tuberculosiscells, gen-
erating large numbers of mutations. The
construction of the shuttle phasmid was
described in the September 1997 issue of
the Proceedings ofthe NationalAcademy of
Sciences. Since then, the researchers have
collected more than 10,000 mutants with a
random distribution of mutations. "We
keep making them, and hopefully we will
statistically accumulate enough to cover all
the genes," says Bloom.
The shuttle phasmid attracted the
attention ofGlaxo Welicome in Stevenage,
United Kingdom. On World TB Day (24
March 1998), Jacobs and Bloom (who
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